Mostrando ítems 1-20 de 760

    Nombre de los autores
    [Abdel-Mannan OA] Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London; Department of Neurology, Great Ormond Street Hospital for Children, London, United Kingdom. [Manchoon C] Children’s Neurosciences, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation, United Kingdom. [Rossor T] Children’s Neurosciences, Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS Foundation, United Kingdom. [Southin JC] Department of Neurology, Alder Hey Children’s NHS Foundation Trust, Liverpool, United Kingdom. [Tur C] Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London. Centre d'Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Brownlee W] Queen Square MS Centre, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, United Kingdom [1]
    [Arnaldos-Pérez C, Naranjo L] Immunology Department, Centre Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain. [Vilaseca A] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Sabater L] Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. [Dalmau J] Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. Department of Neurology, University of Pennsylvania, Philadelphia, PA, United States. [Ruiz-García R] Immunology Department, Centre Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Spain. Neuroimmunology Program, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain [1]
    [Arnett S, Chew SH] School of Medicine and Dentistry, Gold Coast Campus, Grifth University, Gold Coast, Australia. Department of Neurology, Gold Coast University Hospital, Southport, QLD, Australia. [Leitner U] School of Medicine and Dentistry, Gold Coast Campus, Grifth University, Gold Coast, Australia. [Hor JY] Department of Neurology, Penang General Hospital, George Town, Penang, Malaysia. [Paul F] NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, and Berlin Institute of Health, Berlin, Germany. Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Berlin, Germany. [Yeaman MR] Department of Medicine, David Gefen School of Medicine at the University of California, Los Angeles, CA, USA. Department of Medicine, Divisions of Molecular Medicine & Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA, USA. Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, USA. [Arrambide G] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain [1]
    [Arnold DL] Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada. NeuroRx Research, Montreal, Quebec, Canada. [Elliott C] NeuroRx Research, Montreal, Quebec, Canada. [Martin EC] EMD Serono, Billerica, MA. [Hyvert Y] The Healthcare Business of Merck KGaA, Darmstadt, Germany. [Tomic D] Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany. [Montalban X] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain [1]
    [Balk LJ, Coric D] Department of Neurology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands. [Knier B] Department of Neurology, Klinikum rechts der Isar, Technische Universität München, Germany. [Zimmermann HG] Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany. Berlin Institute of Health, NeuroCure Clinical Research Center, Berlin, Germany. [Behbehani R] Al-Bahar Ophthalmology Centre, Ibn Sina Hospital, Kuwait. [Alroughani R] Division of Neurology, Department of Medicine, Amiri Hospital, Kuwait. [Vidal-Jordana A] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Servei de Neuroimmunologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Montalban X] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Servei de Neuroimmunologia Clínica, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Division of Neurology, Department of Medicine, St. Michael's Hospital, University of Toronto, Canada [1]
    [Bar-Or A] Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Hu X] Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. [Kropshofer H, Kukkaro P, Coello N] Novartis Pharma AG, Basel, Switzerland [1]
    [Bar-Or A] Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. [Wiendl H] Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany. [Montalban X] Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Alvarez E] Department of Neurology, Rocky Mountain MS Center, University of Colorado, Aurora, CO, USA. [Davydovskaya M] Pirogov Russian National Research Medical University, Moscow, Russian Federation. [Delgado SR] MS Center and Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA [1]
    [Behrens M, Lünemann JD] Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany. [Comabella M] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain [1]
    [Bittner S, Zipp F] Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz 55131, Germany. [Oh J] Division of Neurology, Department of Medicine, St Michael’s Hospital, University of Toronto, Toronto, Ontario M5S 3H2, Canada. [Kubala Havrdová E] Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague 116 36, Czech Republic. [Tintoré M] Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain [1]
    [Boaventura M, Sastre-Garriga J, Vidal-Jordana A, Quartana D, Carvajal R, Tintoré M, Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Garcia-Vidal A, Auger C, Alberich M, Rovira À, Pareto D] Grup de Recerca en Neuroradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain [1]
    [Boonsuth R, Samson RS, Battiston M] Nuclear Magnetic Resonance Research Unit, Queen Square MS Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom. [Tur C] Nuclear Magnetic Resonance Research Unit, Queen Square MS Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom. Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Grussu F] Nuclear Magnetic Resonance Research Unit, Queen Square MS Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, University College London, London, United Kingdom. Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. Centre for Medical Image Computing, Department of Computer Science, University College London, London, United Kingdom. [Schneider T] Philips Healthcare, Guildford, Surrey, United Kingdom [1]
    [Brochet B] INSERM U 1215, University of Bordeaux, Bordeaux, France. [Alessandra Solari] Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. [Jeannette Lechner-Scott] University of Newcastle, Newcastle, NSW, Australia/ Division of Neurology, John Hunter Hospital, Newcastle, NSW, Australia. [Fredrik Piehl] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. [Dawn Langdon] Department of Psychology, Royal Holloway, University of London, Egham, UK. [Raymond Hupperts] Zuyderland Medisch Centrum Sittard, Maastricht University Medical Center, Maastricht, The Netherlands. [Xavier Montalban] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain [1]
    [Brochet B] INSERM U 1215, University of Bordeaux, Bordeaux, France. [Hupperts R] Department of Psychology, Royal Holloway, University of London, Egham, United Kingdom. [Langdon D] Department of Psychology, Royal Holloway, University of London, Egham, United Kingdom. [Solari A] Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. [Piehl F] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. [Lechner-Scott J] University of Newcastle, Newcastle, NSW, Australia. Division of Neurology, John Hunter Hospital, Newcastle, NSW, Australia. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain [1]
    [Brochet B] INSERM U 1215, University of Bordeaux, Bordeaux, France. [Solari A] Unit of Neuroepidemiology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. [Lechner-Scott J] University of Newcastle, Newcastle, NSW, Australia. Division of Neurology, John Hunter Hospital, Newcastle, NSW, Australia. [Piehl F] Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. [Langdon D] Department of Psychology, Royal Holloway, University of London, Egham, UK. [Hupperts R] Zuyderland Medisch Centrum Sittard, Maastricht University Medical Center, Maastricht, The Netherlands. [Montalban N] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain [1]
    [Brownlee WJ] Queen Square Multiple Sclerosis Center, Department of Neuroinflammation, UCL Institute of Neurology, London, UK. NIHR University College London Hospitals Biomedical Research Center, London, UK. [Vidal-Jordana A, Bollo L, Sastre-Garriga J] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Shatila M] Queen Square Multiple Sclerosis Center, Department of Neuroinflammation, UCL Institute of Neurology, London, UK. [Strijbis E, Schoof L, Killestein J] Multiple Sclerosis Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical College VUMC, Amsterdam, the Netherlands. [Rovira A] Secció of Neuroradiologia, Servei de Radiodiagnòstic, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Tintore M, Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Universitat de Vic-Universitat Central de Catalunya, Vic, Spain [1]
    [Cagol A] Translational Imaging in Neurology Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland. Department of Neurology, University Hospital Basel, Switzerland. Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University of Basel, Basel, Switzerland. Department of Health Sciences, University of Genova, Genova, Italy. [Cortese R] Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, University College London Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, United Kingdom. [Barakovic M] Translational Imaging in Neurology Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland. Department of Neurology, University Hospital Basel, Switzerland. Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University of Basel, Basel, Switzerland. [Schaedelin S] Department of Neurology, University Hospital Basel, Switzerland. Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University of Basel, Basel, Switzerland. Department of Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland. [Ruberte E] Translational Imaging in Neurology Basel, Department of Biomedical Engineering, University Hospital Basel and University of Basel, Basel, Switzerland. Department of Neurology, University Hospital Basel, Switzerland. Research Center for Clinical Neuroimmunology and Neuroscience Basel, University Hospital Basel and University of Basel, Basel, Switzerland. Medical Image Analysis Center, Basel, Switzerland. [Absinta M] Institute of Experimental Neurology, Division of Neuroscience, Vita-Salute San Raffaele University and Istituto di Ricovero e Cura a Carattere Scientifico, San Raffaele Scientific Institute, Milan, Italy. [Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Bellaterra, Spain. Division of Neurology, St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada. [Rovira À] Secció de Neuroradiologia, Servei de Radiodiagnòstic, Vall d’Hebron Hospital Universitari, Universitat Autònoma de Barcelona, Bellaterra, Spain [1]
    [Calvi A, Chard D, Stutters J, Ciccarelli O] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), United Kingdom. [Tur C] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), United Kingdom. Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Cortese R] Dep. of Medicine, Surgery and Neuroscience, University of Siena, Italy [1]
    [Calvi A] NMR Research Unit, Institute of Neurology, University College London, London, UK. Laboratory of Advanced Imaging in Neuroimmunological Diseases, Hospital Clinic Barcelona, Fundació Clinic per a la Recerca Biomèdica, Barcelona, Spain. [Mendelsohn Z] NMR Research Unit, Institute of Neurology, University College London, London, UK. Department of Radiology, Charité School of Medicine and University Hospital Berlin, Berlin, Germany. [Hamed W] NMR Research Unit, Institute of Neurology, University College London, London, UK. Department of Radiology, Mansoura University Hospital, Mansoura, Egypt. [Chard D] NMR Research Unit, Institute of Neurology, University College London, London, UK. National Institute for Health Research, Biomedical Research Centre, University College London Hospitals, London, UK. [Tur C] NMR Research Unit, Institute of Neurology, University College London, London, UK. Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Stutters J] NMR Research Unit, Institute of Neurology, University College London, London, UK [1]
    [Calvi A] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK. [Clarke MA, Alberich M, Pareto D, Rovira A] Secció de Neuroradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Prados F, Chard D, Ciccarelli O] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK. Biomedical Research Centre, National Institute for Health Research (NIHR) and University College London Hospitals (UCLH), London, UK. [Rodríguez Barranco M, Sastre-Garriga J] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Tur C] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK. Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Barkhof F] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK/Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London, UK Biomedical Research Centre, National Institute for Health Research (NIHR) and University College London Hospitals (UCLH), London, UK/Radiology & Nuclear medicine, VU University Medical Centre, Amsterdam, The Netherlands [1]
    [Carrión B, Liu Y, Hadi M, Lundstrom J] Biotech Research and Innovation Centre (BRIC), University of Copenhagen. [Christensen JR, Ammitzbøll C] Danish Multiple Sclerosis Center, University of Copenhagen and Department of Neurology, Rigshospitalet. [Comabella M, Montalban X] Unitat de Neuroimmunologia Clínica, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain [1]